Agents targeting CD138 and uses thereof

Details for Australian Patent Application No. 2008339910 (hide)

Owner Biotest AG

Inventors Daelken, Benjamin; Kraus, Elmar; Bruecher, Christoph; Osterroth, Frank; Aigner, Silke; Germer, Matthias; Zeng, Steffen; Uherek, Christoph

Agent Griffith Hack

Pub. Number AU-A-2008339910

PCT Pub. Number WO2009/080829

Priority 61/016,630 26.12.07 US

Filing date 23 December 2008

Wipo publication date 2 July 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080829 Priority application(s): WO2009/080829

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339911-Immunoconjugates targeting CD138 and uses thereof

2008339909-Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease